Clinical Trial Update: EPIPAGE2 Cohort Study Follow up at Five and a Half Years

View source ↗

Summary

The EPIPAGE2 cohort study has completed follow-up at five and a half years for children born very preterm in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Very Preterm Birth | Status: COMPLETED